AddLife (1AD1) Stock Overview
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
1AD1 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Looking to be second time lucky with a game-changing new product
Key Takeaways Unicycive has successfully completed clinical development of its lead asset, Oxylanthanum Carbonate (OLC). OLC has been designed to improve on current phosphate binders by offering better efficacy, fewer pills, and improved tolerability over alternative treatments for hyperphosphatemia chronic kidney disease patients on dialysis.Read more
AddLife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 13.13 |
| 52 Week High | SEK 19.01 |
| 52 Week Low | SEK 12.40 |
| Beta | 1.79 |
| 1 Month Change | -5.13% |
| 3 Month Change | -19.20% |
| 1 Year Change | 2.02% |
| 3 Year Change | 48.70% |
| 5 Year Change | -16.69% |
| Change since IPO | 106.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1AD1 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -4.0% | -5.2% | -0.9% |
| 1Y | 2.0% | -24.4% | 0.3% |
Return vs Industry: 1AD1 exceeded the German Life Sciences industry which returned -22.4% over the past year.
Return vs Market: 1AD1 exceeded the German Market which returned -0.2% over the past year.
Price Volatility
| 1AD1 volatility | |
|---|---|
| 1AD1 Average Weekly Movement | 6.2% |
| Life Sciences Industry Average Movement | 7.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in DE Market | 14.4% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 1AD1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 1AD1's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 2,295 | Fredrik Dalborg | www.add.life |
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment.
AddLife AB (publ) Fundamentals Summary
| 1AD1 fundamental statistics | |
|---|---|
| Market cap | €1.61b |
| Earnings (TTM) | €51.99m |
| Revenue (TTM) | €969.40m |
Is 1AD1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1AD1 income statement (TTM) | |
|---|---|
| Revenue | SEK 10.44b |
| Cost of Revenue | SEK 6.47b |
| Gross Profit | SEK 3.98b |
| Other Expenses | SEK 3.42b |
| Earnings | SEK 560.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 01, 2026
| Earnings per share (EPS) | 4.60 |
| Gross Margin | 38.09% |
| Net Profit Margin | 5.36% |
| Debt/Equity Ratio | 78.4% |
How did 1AD1 perform over the long term?
See historical performance and comparisonDividends
Does 1AD1 pay a reliable dividends?
See 1AD1 dividend history and benchmarks| AddLife dividend dates | |
|---|---|
| Ex Dividend Date | May 07 2026 |
| Dividend Pay Date | May 13 2026 |
| Days until Ex dividend | 54 days |
| Days until Dividend pay date | 60 days |
Does 1AD1 pay a reliable dividends?
See 1AD1 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 18:02 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AddLife AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Karl Norén | Danske Bank |
| Robert Redin | DNB Carnegie |
| Gustav Berneblad | Nordea Markets |